EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Development of Redox-Active Lyotropic Lipid Cubic Phases for Biosensing Platforms

Wanli Liu iD, Simon E Lewis iD, Mirella di Lorenzo iD, Adam M Squires iD

Langmuir · 2024

DOI: 10.1021/acs.langmuir.3c02307 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Langmuir, 2024. Verfasst von Wanli Liu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of Bath, Bath BA2 7AY, U.K. Hauptthemen laut MEDLINE: Glucose, Biosensing Techniques. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Enzyme-based electrochemical biosensors play an important role in point-of-care diagnostics for personalized medicine. For such devices, lipid cubic phases (LCP) represent an attractive method to immobilize enzymes onto conductive surfaces with no need for chemical linking. However, research has been held back by the lack of effective strategies to stably co-immobilize enzymes with a redox shuttle that enhances the electrical connection between the enzyme redox center and the electrode. In this study, we show that a monoolein (MO) LCP system doped with an amphiphilic redox mediator (ferrocenylmethyl)dodecyldimethylammonium bromide (Fc12) can be used for enzyme immobilization to generate an effective biosensing platform. Small-angle X-ray scattering (SAXS) showed that MO LCP can incorporate Fc12 while maintaining the Pn3m symmetry morphology. Cyclic voltammograms of Fc12/MO showed quasi-reversible behavior, which implied that Fc12 was able to freely diffuse in the lipid membrane of LCP with a diffusion coefficient of 1.9 ± 0.2 × 10-8 cm2 s-1 at room temperature. Glucose oxidase (GOx) was then chosen as a model enzyme and incorporated into 0.2%Fc12/MO to evaluate the activity of the platform. GOx hosted in 0.2%Fc12/MO followed Michaelis-Menten kinetics toward glucose with a KM and Imax of 8.9 ± 0.5 mM and 1.4 ± 0.2 μA, respectively, and a linearity range of 2-17 mM glucose. Our results therefore demonstrate that GOx immobilized onto 0.2% Fc12/MO is a suitable platform for the electrochemical detection of glucose.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlucoseBiosensing TechniquesScattering, Small AngleX-Ray DiffractionOxidation-ReductionGlucose OxidaseEnzymes, ImmobilizedElectrodes

Substanzen

GlucoseGlucose OxidaseEnzymes, Immobilized

Autor:innen und Institutionen

  • Department of Chemistry, University of Bath, Bath BA2 7AY, U.K.
  • Department of Chemical Engineering, University of Bath, Bath BA2 7AY, U.K.

ORCID-Profile: Wanli Liu, Simon E Lewis, Mirella di Lorenzo, Adam M Squires

Zitieren

APA

Liu, W., Lewis, S. E., di Lorenzo, M., & Squires, A. M. (2024). Development of Redox-Active Lyotropic Lipid Cubic Phases for Biosensing Platforms. Langmuir. https://doi.org/10.1021/acs.langmuir.3c02307

Vancouver

Liu W, Lewis SE, di Lorenzo M, Squires AM. Development of Redox-Active Lyotropic Lipid Cubic Phases for Biosensing Platforms. Langmuir. 2024. doi:10.1021/acs.langmuir.3c02307

BibTeX
@article{Liu2024,
  author = {Liu, Wanli and Lewis, Simon E and di Lorenzo, Mirella and Squires, Adam M},
  title = {Development of Redox-Active Lyotropic Lipid Cubic Phases for Biosensing Platforms},
  journal = {Langmuir},
  year = {2024},
  doi = {10.1021/acs.langmuir.3c02307}
}
Kostenlos starten →